The Ukrainian pharmaceutical market is gradually recovering.

According to the results of the first six months of 2023, the medical product sales volume in Ukraine exceeded 420 million packages. Sales of drugs in natural terms during the half year decreased by only 6.4% compared to the same period in 2022, while according to the results from the first quarter, the drop was about 25%. This indicates the restoration of the pre-war pace of Ukraine’s drug production, reported the pharmaceutical company, Darnytsia.

At the same time, it is noted that in monetary terms, the pharmaceutical industry has shown significant growth: sales volumes reached UAH 62.5B, which is UAH 11.7B, or 23%, higher than the total figure for the first two quarters of 2022. According to the results from the first half of 2023, 63% of medicinal products sold in Ukraine are of Ukrainian production.